Welcome to visit Zhongnan Medical Journal Press Series journal website!
Zhongnan Medical Journal Press
Series of Journals
Center for Evidence-Based and Translational Medicine of Wuhan University
The title
The title
The keywords
The author
Submit
Home
About us
Journal Introduction
Chief Editor
Editorial Committee
Author Center
Submission Guide
Assignment Agreement
Articles
Subscribe
Copyright
Contact us
Draft submission system
Author login
Author register
Reviewer login
Editor login
Home
Articles
Vol 33,2024 No.1
The title
The title
The keywords
The author
New Online
Vol 33,2024
Vol 32,2023
No.10
No.9
No.8
No.7
No.6
No.5
No.4
No.3
No.2
No.1
Contents
Vol 33,2024 No.1
Date of publication: January 15, 2024
Get cover
Get contents
Next
Vol 33,2024 No.2
Prev
Vol 32,2023 No.12
Yearly-end Thanks and Prospects
ZHAN Siyan
XIN Huawen
ZHAI Suodi
2024,33(1):1
Details
Download
Mobile
Analysis of medical disputes related to drug-induced cross-allergy and study on prescripition review strategy
LI Wei
ZHANG Chengliang
XUE Pinpin
DU Jinfeng
LIU Dong
2024,33(1):2-8
Cross-allergy
Medical disputes
Tort liability
Prescription review
Adverse drug reactions
Details
Download
Mobile
Review and risk information management of neuropathy induced by emerging anti-tumor drugs
LYU Feng
SONG Wei
XIN Mengru
XIE Di
ZHANG Wenqing
HE Wen
HU Hankun
2024,33(1):9-18
Emerging anti-tumor drugs
Drug-induced neuropathy
Drug risk information management
Details
Download
Mobile
National competent authority regulation and practice of drug benefit-risk communication in the United States, European Union and China
ZHANG Yinan
WU Tingxi
ZHAO Zhigang
2024,33(1):19-27
Drug benefit-risk communication
Safety communication
Drug safety information
Pharmacovigilance
Details
Download
Mobile
Mining pharmacovigilance signals for asthma adverse events in underage population based on the FAERS database
CHEN Yan
LI Bing
LIU Xia
LIU Hongyan
SHAN Qing
GUO Jinmin
2024,33(1):28-36
Asthma
Underage population
FAERS database
Data mining
Pharmacovigilance
Details
Download
Mobile
Analysis of the characteristics and risk factors of levofloxacin-induced arrhythmias
GUO Haili
GUO Daihong
ZHU Man
LI Peng
FU An
LI Chao
LU Jingchuan
2024,33(1):37-44
Levofloxacin
Arrhythmia
Risk factors
Automatic monitoring
Propensity score matching
Details
Download
Mobile
Association of PPIs use with short-term and long-term mortality risk in patients with severe ischemic stroke: a retrospective cohort study based on the MIMIC-Ⅲ database
QIN Sisi
ZHANG Huitao
PAN Haiyan
ZHU Yaoli
ZENG Li
2024,33(1):45-51
Proton pump inhibitors
Severe ischemic stroke
Mortality risk
MIMIC-Ⅲ database
Details
Download
Mobile
Clinical observation of Zishen Ningxin capsule combined with telmisartan in the treatment of perimenopausal hypertension
WANG Bei
DU Mingmin
WANG Chengyi
FU Da
ZHANG Jing
WANG Qiang
2024,33(1):52-59
Zishen Ningxin capsule
Telmisartan
Perimenopause
Hypertension
Details
Download
Mobile
Cost-utility analysis of budesonide/formoterol powder inhalation versus salmeterol/fluticasone powder inhalation for asthma in adolescents
SHEN Anle
WU Bin
LIU Dan
JIANG Yuelian
WU Juan
YIN Yong
ZHANG Shunguo
2024,33(1):60-67
Budesonide/formoterol
Salmeterol/fluticasone
Cost-utility analysis
Asthma
Adolescent
Details
Download
Mobile
Cost-utility analysis of edaravone dexborneol for acute ischemic stroke
ZHOU Shasha
CHEN Xiangfan
CHEN Xia
2024,33(1):68-74
Edaravone dexborneol
Edaravone
Acute ischemic stroke
Decision tree model
Cost-utility analysis
Details
Download
Mobile
Teriparatide treatment for osteoporosis: a rapid health technology assessment
LYU Peng
ZHANG Jingli
WAN Yuansheng
HUANG Yifei
YOU Ruxu
2024,33(1):75-84
Teriparatide
Osteogenesis
Safety
Effectiveness
Economy
Rapid health technology assessment
Details
Download
Mobile
Efficacy and safety of budesonide combined with pulmonary surfactant in the treatment of neonatal meconium aspiration syndrome: a systematic review
ZHANG Yiwei
TANG Xiaoyu
LI Sheng
LIU Tao
LEI Liang
TAN Lu
HU Juan
2024,33(1):85-94
Budesonide
Pulmonary surfactant
Meconium aspiration syndrome
Meta-analysis
Systematic review
Randomized controlled trial
Details
Download
Mobile
Research progress of medication-related patient-reported outcome scales
LU Panpan
LI Haixin
DENG Zhiling
LIANG Xujian
LU Yiting
YAN Ming
CAI Songtao
LI Wanchao
ZENG Ruifeng
GUO Yi
XU Zhijie
2024,33(1):95-105
Medication treatment
Patient reported outcome
Scale
Research progress
Details
Download
Mobile
Clinical pharmacists participating in the analysis of drug therapy for a case of Bartonella henselae meningitis
PENG Tingting
YANG Ruixi
NING Hong
TIAN Yalan
2024,33(1):106-110
Bartonella henselae meningitis
Anti-infective therapy
Pharmaceutical care
Details
Download
Mobile
A case analysis of liver injury induced by gefitinib
XU Pei
ZHANG Mi
XIONG Xin
HUANG Lu
2024,33(1):111-115
Gefitinib
Liver injury
Adverse drug reaction
Details
Download
Mobile
A case of pituitary crisis caused by cadonilimab treatment of advanced gastric cancer
XU Qian
XU Ting
2024,33(1):116-120
Cadonilimab
Pituitary crisis
Immune-related adverse event
Adverse drug reaction
Details
Download
Mobile